)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Abeona Therapeutics
Abeona Therapeutics (ABEO) investor relations material
Abeona Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary12 Jun, 2026
Opening remarks and agenda
Meeting opened with acknowledgment of Michael Amoroso's resignation from the board for personal reasons, not related to company matters.
Michael Amoroso's name withdrawn from board election; no replacement nominated.
Principal agenda items included director elections, executive compensation, auditor ratification, equity plan amendment, and certificate of incorporation amendment.
Board and executive committee updates
Michael Amoroso thanked for years of service; his resignation effective prior to the meeting.
No replacement director nominated for election at this meeting.
Shareholder proposals
Election of two Class I Directors for three-year terms.
Advisory approval of executive compensation.
Ratification of Deloitte & Touche LLP as independent auditor for 2026.
Approval sought to increase shares reserved under the 2023 Equity Incentive Plan from $8.4M to $11.5M.
Proposal to amend certificate of incorporation to remove advance notice provision for director nominations.
Reason for Michael Amoroso's board resignation
Details on the 2023 Equity Incentive Plan increase
Outcome of the director nomination rule change
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Abeona Therapeutics
- PZ-cel nears FDA approval with Q3 2025 launch targeted and cash runway into 2026.ABEO
Q4 20249 Jul 2026 - Q1 2026 saw $8.7M ZEVASKYN revenue, $17.1M net loss, and a shift to oncology pipeline.ABEOQ1 20268 Jul 2026
- Q2 net income reached $7.4M as pz-cel BLA resubmission and launch prep advance for H2 2024.ABEOQ2 20248 Jul 2026
- Lead cell therapy for RDEB advances toward approval, with strong clinical data and commercial readiness.ABEOStifel Virtual Cell Therapy Forum8 Jul 2026
- ZEVASKYN achieves durable RDEB wound healing, fueling growth and pipeline expansion.ABEOInvestor presentation12 Jun 2026
- Strong launch momentum, expanding access, and robust pipeline drive growth outlook.ABEOJefferies Global Healthcare Conference 20265 Jun 2026
- ZEVASKYN delivers durable healing for RDEB, driving strong demand and a $4B US market opportunity.ABEOCorporate presentation4 Jun 2026
- Key votes include director elections, equity plan expansion, and governance changes.ABEOProxy filing4 May 2026
- Board recommends approval of all five key proposals at the 2026 annual meeting.ABEOProxy filing27 Apr 2026
Next Abeona Therapeutics earnings date
Q2 202611 Aug, 2026
Abeona Therapeutics
Next Abeona Therapeutics earnings date
Q2 202611 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage